Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease von Ataga, Kenneth I, Kutlar, Abdullah, Kanter, Julie, Liles, Darla, Cancado, Rodolfo, Friedrisch, João, Guthrie, Troy H, Knight-Madden, Jennifer, Alvarez, Ofelia A, Gordeuk, Victor R, Gualandro, Sandra, Colella, Marina P, Smith, Wally R, Rollins, Scott A, Stocker, Jonathan W, Rother, Russell P

Volltext

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease von Vichinsky, Elliott, Hoppe, Carolyn C, Ataga, Kenneth I, Ware, Russell E, Nduba, Videlis, El-Beshlawy, Amal, Hassab, Hoda, Achebe, Maureen M, Alkindi, Salam, Brown, R. Clark, Diuguid, David L, Telfer, Paul, Tsitsikas, Dimitris A, Elghandour, Ashraf, Gordeuk, Victor R, Kanter, Julie, Abboud, Miguel R, Lehrer-Graiwer, Joshua, Tonda, Margaret, Intondi, Allison, Tong, Barbara, Howard, Jo

Volltext

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease von Kanter, Julie, Walters, Mark C, Krishnamurti, Lakshmanan, Mapara, Markus Y, Kwiatkowski, Janet L, Rifkin-Zenenberg, Stacey, Aygun, Banu, Kasow, Kimberly A, Pierciey, Francis J, Bonner, Melissa, Miller, Alex, Zhang, Xinyan, Lynch, Jessie, Kim, Dennis, Ribeil, Jean-Antoine, Asmal, Mohammed, Goyal, Sunita, Thompson, Alexis A, Tisdale, John F

Volltext

Challenges to Management of Pain in Sickle Cell Disease von Kanter, Julie

Volltext

Perspectives of individuals with sickle cell disease on barriers to care von Phillips, Shannon, Chen, Yumei, Masese, Rita, Noisette, Laurence, Jordan, Kasey, Jacobs, Sara, Hsu, Lewis L, Melvin, Cathy L, Treadwell, Marsha, Shah, Nirmish, Tanabe, Paula, Kanter, Julie

Volltext

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab von Marsh, Rebecca A., Allen, Carl E., McClain, Kenneth L., Weinstein, Joanna L., Kanter, Julie, Skiles, Jodi, Lee, Nadine D., Khan, Shakila P., Lawrence, Julia, Mo, Jun Q., Bleesing, Jack J., Filipovich, Alexandra H., Jordan, Michael B.

Volltext

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease von Osunkwo, Ifeyinwa, Manwani, Deepa, Kanter, Julie

Volltext

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study von Kanter, Julie, Thompson, Alexis A., Pierciey, Francis J., Hsieh, Matthew, Uchida, Naoya, Leboulch, Philippe, Schmidt, Manfred, Bonner, Melissa, Guo, Ruiting, Miller, Alex, Ribeil, Jean‐Antoine, Davidson, David, Asmal, Mohammed, Walters, Mark C., Tisdale, John F.

Volltext

Density-based separation in multiphase systems provides a simple method to identify sickle cell disease von Kumar, Ashok A., Patton, Matthew R., Hennek, Jonathan W., Lee, Si Yi Ryan, D'Alesio-Spina, Gaetana, Yang, Xiaoxi, Kanter, Julie, Shevkoplyas, Sergey S., Brugnara, Carlo, Whitesides, George M.

Volltext

Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium von Masese, Rita V, Bulgin, Dominique, Knisely, Mitchell R, Preiss, Liliana, Stevenson, Eleanor, Hankins, Jane S, Treadwell, Marsha J, King, Allison A, Gordeuk, Victor R, Kanter, Julie, Gibson, Robert, Glassberg, Jeffrey A, Tanabe, Paula, Shah, Nirmish

Volltext

Factors associated with left ventricular hypertrophy in children with sickle cell disease; results from the DISPLACE study von Galadanci, Najibah A, Johnson, Walter, Carson, April, Hellemann, Gerhard, Howard, Virginia, Kanter, Julie

Volltext

48847 Assessing Transition Outcomes in Sickle Cell Disease (SCD) Prior To Implementation of A Formal Transition Program von Sheppard, Sydney, Kanter, Julie

Volltext

Current Methods of Newborn Screening Follow-Up for Sickle Cell Disease Are Highly Variable and without Quality Assurance: Results from the ENHANCE Study von Galadanci, Najibah, Phillips, Shannon, Schlenz, Alyssa, Ivankova, Nataliya, Kanter, Julie

Volltext

Simple paper-based test for measuring blood hemoglobin concentration in resource-limited settings von Yang, Xiaoxi, Piety, Nathaniel Z, Vignes, Seth M, Benton, Melody S, Kanter, Julie, Shevkoplyas, Sergey S

Volltext

Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry von Glassberg, Jeffrey A, Linton, Elizabeth A, Burson, Katrina, Hendershot, Tabitha, Telfair, Joseph, Kanter, Julie, Gordeuk, Victor R, King, Allison A, Melvin, Cathy L, Shah, Nirmish, Hankins, Jane S, Epié, Axel Yannick, Richardson, Lynne D

Volltext

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers i... von Smeltzer, Matthew P, Howell, Kristen E, Treadwell, Marsha, Preiss, Liliana, King, Allison A, Glassberg, Jeffrey A, Tanabe, Paula, Badawy, Sherif M, DiMartino, Lisa, Gibson, Robert, Kanter, Julie, Klesges, Lisa M, Hankins, Jane S

Volltext

Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia von Piety, Nathaniel Z, Yang, Xiaoxi, Kanter, Julie, Vignes, Seth M, George, Alex, Shevkoplyas, Sergey S

Volltext

Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry von Mendez, Gustavo G, Nocek, Judith M, Brambilla, Donald J, Jacobs, Sara, Cole, Oladipo, Kanter, Julie, Glassberg, Jeffrey, Saving, Kay L, Melvin, Cathy L, Gibson, Robert W, Treadwell, Marsha, Jackson, George L, King, Allison A, Gordeuk, Victor R, Kroner, Barbara, Hsu, Lewis L

Volltext

PB2524: TRIAL IN PROGRESS: THE HIBISCUS‐KIDS STUDY, A SINGLE‐ARM, OPEN‐LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH S... von Colombatti, Raffaella, Kanter, Julie, Wu, Eric, Clay, Leila J., Campbell, Andrew

Volltext

Gene therapy for sickle cell disease: where we are now? von Kanter, Julie, Falcon, Corey

Volltext